The State Department’s global health chief is on the lookout for “the next lenacapavir” — but this time, he hopes that will mean an innovation for tuberculosis instead of HIV.
“We’re thinking, alongside these [memorandums of understanding] that we’re signing with governments, how do we set aside [money] for innovations?” said Jeffrey Graham, the senior bureau official for the State Department’s Bureau of Global Health Security and Diplomacy, speaking at a tuberculosis-focused briefing for congressional staffers on Tuesday.
“A scalable, innovative invention that not only can change the course of an epidemic, but also for us, as stewards of taxpayer dollars in the U.S., that can help us move away from being forever donors,” he added.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Elissa Miolene
Elissa Miolene covers U.S. foreign assistance from Washington, D.C. She previously covered education at The San Jose Mercury News, and has written for The Wall Street Journal, the San Francisco Chronicle, and other news outlets across the world. Before shifting to journalism, Elissa led communications for aid agencies in the United States, East Africa, and South Asia.
Search for articles
Most Read
- 1
- 2
- 3
- 4
- 5